Ototoxic Hearing Loss
5 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Intratympanic Administration of N-acetylcysteine for Protection of Cisplatin-induced Ototoxicity (NCT04226456) | Centre Hospitalier Universitaire Saint Pierre | 2021-07-10 |
| Intratympanic N-Acetylcysteine for Prevention of Cisplatin-induced Ototoxicity. (NCT04291209) | Sunnybrook Health Sciences Centre | 2020-02-26 |
Track Ototoxic Hearing Loss automatically
Every clearance here is in the API, with alerts when new ones post.